A drag-along right is a provision that enables a majority shareholder to force a minority shareholder to join in the sale of a company

Bristol-Myers Squibb acquired Celgene in 2019 and the majority shareholders held 69%. The minority shareholders were dragged along in the acquisition at the same terms set by the majority.